Cellectis S.A. current report, Q3 FY2019

Cellectis S.A. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K, filed on August 6, 2019, by Cellectis S.A., a foreign private issuer based in Paris, France, incorporates by reference the company's interim report for the three-month and six-month periods ended June 30, 2019. The filing serves to update U.S. investors on the company's recent operational and financial status.

Key Financial Metrics

The provided text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached Exhibit 99.1 (the interim report), which is referenced but not included in the text of this filing summary.

Material Changes

The filing text does not disclose specific material changes versus prior periods. It solely indicates that the interim report for the periods ended June 30, 2019, is attached as an exhibit.

Guidance, Outlook, and Risks

No management commentary, forward-looking guidance, specific risk factors, or unusual items are detailed in the text of this Form 6-K. The document functions as a cover sheet to incorporate the detailed interim report by reference into the company's existing registration statements (Form F-3 and Form S-8).

Investor Verification Checklist

  • Review Exhibit 99.1 (Interim Report) for actual financial figures for the three and six months ended June 30, 2019.
  • Verify the incorporation of this report into registration statements Nos. 333-217086, 333-204205, 333-214884, 333-222482, and 333-227717.
  • Confirm the company's continued status as a registrant filing under Form 20-F.